The pharmaceutical market for obesity therapies

D Wong, K Sullivan, G Heap - Nature reviews. Drug discovery, 2012 - nature.com
Obesity has become one of the most significant public health challenges of the twenty-first
century. As a primary risk factor for type 2 diabetes, it is closely associated with the metabolic …
被引用次数：60 相关文章

The pharmaceutical market for obesity therapies.

D Wong, K Sullivan, G Heap - Nature Reviews Drug …, 2012 - search.ebscohost.com
The article provides information on the pharmaceutical market for the treatment of obesity. It
mentions that dexfenfluramine and fenfluramine are two of the most notable withdrawn …

[引用][C] The pharmaceutical market for obesity therapies.

D Wong, K Sullivan, G Heap - Nature reviews. Drug Discovery, 2012 - europepmc.org
The pharmaceutical market for obesity therapies. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

The pharmaceutical market for obesity therapies

D Wong, K Sullivan, G Heap - Nature Reviews Drug Discovery, 2012 - go.gale.com
Obesity has become one of the most significant public health challenges of the twenty-first
century. As a primary risk factor for type 2 diabetes, it is closely associated with the metabolic …

[引用][C] The pharmaceutical market for obesity therapies

D Wong, K Sullivan, G Heap - Nature reviews. Drug …, 2012 - pubmed.ncbi.nlm.nih.gov

[引用][C] The pharmaceutical market for obesity therapies

D Wong, K Sullivan, G Heap - Nature Reviews. Drug …, 2012 - Nature Publishing Group